Trials / Unknown
UnknownNCT03162185
Serotonin and Motor Plasticity
The Effects of Serotonergic Challenge on Motor Learning and Neuroplasticity
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Max Planck Institute for Human Cognitive and Brain Sciences · Academic / Other
- Sex
- Female
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
With this study, the investigators aim to test whether acute administration of selective serotonin reuptake inhibitors (SSRI) improves motor performance in a sequential motor learning task in comparison to placebo in healthy humans.
Detailed description
Microdialysis findings in animal models provide evidence for a monoaminergic augmentation of motor function. However, this evidence is largely limited to noradrenaline and dopamine, with little evidence to support a similar effect for serotonin. What remains to be tested therefore, is whether acute serotonergic administration induces neural or behavioral changes during motor learning also. Using a sample of 60 female participants (with the possible inclusion of male participants at a later date), the investigators aim to test the effects of a serotonergic challenge on motor learning and plasticity in healthy participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Escitalopram | Experimental group participants (n = 30) will receive 20 mg of Escitalopram for 7 days. |
| DRUG | Placebo | Control group participants (n = 30) will receive a placebo for 7 days. |
Timeline
- Start date
- 2017-04-01
- Primary completion
- 2017-11-30
- Completion
- 2017-11-30
- First posted
- 2017-05-22
- Last updated
- 2017-05-22
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03162185. Inclusion in this directory is not an endorsement.